J&J | Należności Handlowe



Trade Debtors Zmiana Data
AbbVie USD 10.92B 553M 2024-12
Abbott USD 9.67B 2.74B 2025-03
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.82B 16M 2025-03
Baxter International USD 1.73B 53M 2024-12
Bayer EUR 12.5B 1.33B 2024-12
Becton, Dickinson and Co. USD 2.64B 395M 2024-12
Biogen USD 1.87B 119.3M 2024-12
Boston Scientific USD 2.56B 57M 2024-12
Bristol-Myers Squibb USD 14.59B 162M 2025-03
CONMED USD 237.73M 6.5M 2024-12
Cooper Companies USD 716.4M 600K 2025-01
Dexcom USD 1.03B 100K 2024-12
Edwards Lifesciences USD 727.4M 84.1M 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Globus Medical USD 578.33M 14.87M 2024-12
Hologic USD 631.4M 31M 2024-12
Indivior 272M 16M 2025-03
Insulet USD 365.5M 10.1M 2024-12
Integra LifeSciences USD 272.37M 16.24M 2024-12
Intuitive Surgical USD 1.22B 3.9M 2025-03
J&J USD 16.02B 1.18B 2025-03
Medtronic USD 6.12B 145M 2025-01
Merck USD 11.12B 1.06B 2024-12
Merit Medical Systems USD 216.75M 7.58M 2025-03
Novartis USD 9B 854M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Stryker USD 3.99B 251M 2024-12
Tandem Diabetes Care USD 126.56M 11.98M 2025-03
Teva Pharmaceutical Industries USD 3.06B 403M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Zimmer Biomet Holdings USD 1.48B 800K 2024-12
Zoetis USD 1.32B 95M 2024-12



J&J Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.